Vicus Capital has disclosed its latest investment activities in a 13F-HR filing, revealing a total asset value exceeding $1.5 billion as of September 30, 2026. This significant update underscores the firm's strategic positioning in the competitive investment management landscape.

The filing, submitted on November 5, 2026, indicates that Vicus Capital has been actively managing a diverse portfolio, with notable investments in leading companies across various sectors. The firm’s holdings include major players like UnitedHealth Group and Pfizer, reflecting a strong focus on the healthcare and consumer sectors.

Background

Vicus Capital, incorporated in Pennsylvania, operates under the Central Index Key (CIK) 0001544806. The firm specializes in investment management, as indicated by its filings. The latest 13F-HR submission is part of a series of quarterly reports that provide transparency about its investment strategies and holdings.

What the Filing Says

The 13F-HR filing reveals a total of 274 entries, with a cumulative value of $1,578,612,033 in assets managed by Vicus Capital. The firm reported that it holds shares in various companies, demonstrating a well-diversified investment approach.

Impact

This filing is significant for stakeholders, including investors and competitors, as it showcases Vicus Capital's investment strategies and market positioning. The reported holdings may influence market perceptions and strategies among peers in the investment management sector.

What's Next

The filing does not specify any immediate next steps or actions following this update. However, it sets the stage for future disclosures and potential adjustments in investment strategies as market conditions evolve.